Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study (original) (raw)
Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy
Peter Pavan
American Journal of Ophthalmology, 2002
View PDFchevron_right
Vaginal Cytomegalovirus Shedding before and after Initiation of Antiretroviral Therapy in
Paschal Ssebbowa
2016
View PDFchevron_right
Impact of highly active antiretroviral therapy on cytomegalovirus viraemia, in the absence of specific anti-cytomegalovirus therapy
Dan Otelea
Journal of the International AIDS Society, 2008
View PDFchevron_right
Incidence of Cytomegalovirus Retinitis in the Era of Highly Active Antiretroviral Therapy
Jennifer Thorne
American Journal of Ophthalmology, 2012
View PDFchevron_right
Bilateral cytomegalovirus retinitis in a child with acute lymphoblastic leukemia while on maintenance chemotherapy
Vikramjit Kanwar
Pediatric Hematology Oncology Journal, 2016
View PDFchevron_right
Atypical cytomegalovirus retinitis in non-Hodgkin's lymphoma
Vikas Ambiya
BMJ Case Reports, 2015
View PDFchevron_right
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes
Jennifer Thorne
Ophthalmology, 2010
View PDFchevron_right
Cytomegalovirus reactivation and its clinical impact in patients with solid tumors
Richard Greil
Infectious Agents and Cancer, 2015
View PDFchevron_right
Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy
Niamh Keane
HIV Medicine, 2004
View PDFchevron_right
Control of cytomegalovirus retinitis after combination antiretroviral therapy
eva ri
Acta Ophthalmologica Scandinavica, 1999
View PDFchevron_right
Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy
Hopkins Stanley
Clinical infectious …, 2000
View PDFchevron_right
Cytomegalovirus retinitis and antiretroviral treatment: A fifteen year experience
Wilbert Sibanda
Southern African Journal of HIV Medicine, 2022
View PDFchevron_right
Cytomegalovirus infection in transplant recipients
Natalya Maluf
Clinics, 2015
View PDFchevron_right
Cytomegalovirus: A Hospitalization Diary by Hervé Guibert
Joanna Bourke
Biography, 2016
View PDFchevron_right
Late cytomegalovirus disease following liver transplantation
Ahmed Eid
Transplant International, 2003
View PDFchevron_right
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
Yvon Lebranchu
Journal of Antimicrobial Chemotherapy, 2010
View PDFchevron_right
Discontinuation of Secondary Prophylaxis in Patients with Cytomegalovirus Retinitis Who Have Responded to Highly Active Antiretroviral Therapy
Juan Carlos Gonzalez
Clinical Infectious Diseases, 2002
View PDFchevron_right
The role of human cytomegalovirus infection in cancer
Chato Taher
2013
View PDFchevron_right
Concurrent oral cytomegalovirus and herpes simplex virus infection in association with HIV infection
Deborah Greenspan
Oral Surgery, Oral Medicine, Oral Pathology, 1993
View PDFchevron_right
Clinical features and outcomes of AIDS-related cytomegalovirus retinitis in the era of highly active antiretroviral therapy
Cristina Muccioli
Arquivos Brasileiros de Oftalmologia, 2010
View PDFchevron_right
Withdrawal of maintenance therapy for cytomegalovirus retinitis in AIDS patients exhibiting immunological response to HAART
Sandra Bonon
2007
View PDFchevron_right
Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy
Julio Arrizabalaga, Carolina Gutierrez
AIDS, 1999
View PDFchevron_right
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy
Kees Brinkman
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
View PDFchevron_right
Atypical Presentation of Cytomegalovirus Infection in a Liver Transplant Patient
PRAVEEN SHARMA
Journal of Clinical and Experimental Hepatology, 2011
View PDFchevron_right
Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group
Julio Arrizabalaga
AIDS
View PDFchevron_right
Reactivation of Herpes Simplex Virus Type 2 After Initiation of Antiretroviral Therapy
Paschal Ssebbowa
Journal of Infectious Diseases, 2013
View PDFchevron_right
Long‐Lasting Remission of Cytomegalovirus Retinitis without Maintenance Therapy in Human Immunodeficiency Virus‐Infected Patients
Anna Bonjoch
Journal of Infectious Diseases, 1998
View PDFchevron_right
Mortality and progression to AIDS after starting highly active antiretroviral therapy
Peter Reiss
AIDS, 2003
View PDFchevron_right
Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy
Alexy Inciarte
BMC Infectious Diseases, 2019
View PDFchevron_right
Evaluation of the United States Public Health Service Guidelines for Discontinuation of Anticytomegalovirus Therapy After Immune Recovery in Patients With Cytomegalovirus Retinitis
Jennifer Thorne
American Journal of Ophthalmology, 2011
View PDFchevron_right
Cytomegalovirus reactivation after low-dose steroid treatment for hemolytic anemia in a patient with primary Epstein-Barr virus infection
Blaženka Grahovac
Wiener klinische Wochenschrift, 2007
View PDFchevron_right
Cytomegalovirus Retinitis in HIV-Negative Patients: A Practical Management Approach
Vicktoria Vishnevskia-Dai
Ophthalmology, 2015
View PDFchevron_right
Triple-Class Virologic Failure in HIV-Infected Patients Undergoing Antiretroviral Therapy for Up to 10 Years
Federico García
Archives of Internal Medicine, 2010
View PDFchevron_right
Discontinuation of Anticytomegalovirus Therapy in Patients With HIV Infection and Cytomegalovirus Retinitis
Eric Fortin
JAMA, 1999
View PDFchevron_right
HIV associated cytomegalovirus retinitis in Melbourne, Australia
Anthony Hall
Sexually Transmitted Infections, 2000
View PDFchevron_right